Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
5209 | 1588 | 40.9 | 70% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1520 | 6929 | LITHIUM//GLYCOGEN SYNTHASE KINASE 3//GSK 3 |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | INOSITOL MONOPHOSPHATASE | Author keyword | 36 | 60% | 3% | 40 |
2 | INOSITOL | Author keyword | 15 | 16% | 5% | 85 |
3 | INOSITOL DEPLETION | Author keyword | 10 | 73% | 1% | 8 |
4 | IST SCI HSR | Address | 9 | 83% | 0% | 5 |
5 | MYOINOSITOL MONOPHOSPHATASE | Author keyword | 8 | 100% | 0% | 5 |
6 | MYO INOSITOL MONOPHOSPHATASE | Author keyword | 7 | 67% | 0% | 6 |
7 | INOSITOL MONOPHOSPHATES | Author keyword | 6 | 80% | 0% | 4 |
8 | EPI INOSITOL | Author keyword | 6 | 71% | 0% | 5 |
9 | CMP PHOSPHATIDATE | Author keyword | 6 | 100% | 0% | 4 |
10 | MOL NEUROPSYCHOPHARMACOL PROGRAM | Address | 6 | 100% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | INOSITOL MONOPHOSPHATASE | 36 | 60% | 3% | 40 | Search INOSITOL+MONOPHOSPHATASE | Search INOSITOL+MONOPHOSPHATASE |
2 | INOSITOL | 15 | 16% | 5% | 85 | Search INOSITOL | Search INOSITOL |
3 | INOSITOL DEPLETION | 10 | 73% | 1% | 8 | Search INOSITOL+DEPLETION | Search INOSITOL+DEPLETION |
4 | MYOINOSITOL MONOPHOSPHATASE | 8 | 100% | 0% | 5 | Search MYOINOSITOL+MONOPHOSPHATASE | Search MYOINOSITOL+MONOPHOSPHATASE |
5 | MYO INOSITOL MONOPHOSPHATASE | 7 | 67% | 0% | 6 | Search MYO+INOSITOL+MONOPHOSPHATASE | Search MYO+INOSITOL+MONOPHOSPHATASE |
6 | INOSITOL MONOPHOSPHATES | 6 | 80% | 0% | 4 | Search INOSITOL+MONOPHOSPHATES | Search INOSITOL+MONOPHOSPHATES |
7 | EPI INOSITOL | 6 | 71% | 0% | 5 | Search EPI+INOSITOL | Search EPI+INOSITOL |
8 | CMP PHOSPHATIDATE | 6 | 100% | 0% | 4 | Search CMP+PHOSPHATIDATE | Search CMP+PHOSPHATIDATE |
9 | 3 PHOSPHOADENOSINE 5 PHOSPHATE | 4 | 67% | 0% | 4 | Search 3++PHOSPHOADENOSINE+5++PHOSPHATE | Search 3++PHOSPHOADENOSINE+5++PHOSPHATE |
10 | IMPASE | 4 | 56% | 0% | 5 | Search IMPASE | Search IMPASE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MYOINOSITOL MONOPHOSPHATASE | 119 | 76% | 5% | 84 |
2 | MYO INOSITOL 1 PHOSPHATASE | 79 | 88% | 2% | 37 |
3 | ADMINISTERED LITHIUM | 49 | 94% | 1% | 17 |
4 | LITHIUM TREATED RATS | 20 | 56% | 2% | 25 |
5 | INOSITOL 1 4 5 TRISPHOSPHATE ACCUMULATION | 18 | 89% | 1% | 8 |
6 | CEREBRAL CORTEX SLICES | 16 | 34% | 2% | 39 |
7 | BRAIN INOSITOL | 15 | 71% | 1% | 12 |
8 | BRAIN MYOINOSITOL MONOPHOSPHATASE | 14 | 100% | 0% | 7 |
9 | CSF INOSITOL | 14 | 100% | 0% | 7 |
10 | PUTATIVE TARGET | 13 | 27% | 3% | 42 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Anti-bipolar therapy: mechanism of action of lithium | 1999 | 238 | 138 | 64% |
SIGNAL-TRANSDUCTION PATHWAYS - MOLECULAR TARGETS FOR LITHIUMS ACTIONS | 1995 | 236 | 101 | 61% |
LITHIUM AND BRAIN SIGNAL-TRANSDUCTION SYSTEMS | 1994 | 170 | 109 | 66% |
Signaling networks in the pathophysiology and treatment of mood disorders | 2002 | 62 | 107 | 71% |
Overview of the mechanism of action of lithium in the brain: Fifty-year update | 2000 | 78 | 105 | 72% |
INOSITOL MONOPHOSPHATASE - A PUTATIVE TARGET FOR LI+ IN THE TREATMENT OF BIPOLAR DISORDER | 1995 | 88 | 81 | 89% |
The mechanism of lithium action: State of the art, ten years later | 2001 | 82 | 30 | 53% |
STRUCTURE ACID MECHANISM OF INOSITOL MONOPHOSPHATASE | 1995 | 61 | 29 | 90% |
Lithium: Bipolar disorder and neurodegenerative diseases Possible cellular mechanisms of the therapeutic effects of lithium | 2008 | 53 | 153 | 33% |
Lithium and bipolar mood disorder: the inositol-depletion hypothesis revisited | 2005 | 92 | 103 | 35% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | IST SCI HSR | 9 | 83% | 0.3% | 5 |
2 | MOL NEUROPSYCHOPHARMACOL PROGRAM | 6 | 100% | 0.3% | 4 |
3 | MOL NEUROSCI BIOINFORMAT S | 3 | 50% | 0.3% | 4 |
4 | CELLULAR MOL PATHOPHYSIOL | 3 | 20% | 0.8% | 12 |
5 | SECT BIOCHEM PSYCHIAT | 2 | 18% | 0.6% | 9 |
6 | STANLEY BIPOLAR | 2 | 43% | 0.2% | 3 |
7 | STANLEY | 2 | 13% | 0.8% | 12 |
8 | PSYCHIAT BEHAV NEUROSCI PHARMACOL | 1 | 50% | 0.1% | 2 |
9 | UNITE INTERACT MOL CANC | 1 | 50% | 0.1% | 2 |
10 | CELLULAR CLIN NEUROBIOL PROGRAM | 1 | 13% | 0.6% | 9 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000183679 | LITHIUM RATIO//GENOKEY S//SCIONDTU |
2 | 0.0000167188 | ADRENAL DELTA5 3 BETA HSD//REPROD ENDOCRINE PHYSIOL//BIPOLARS |
3 | 0.0000106146 | DIACYLGLYCEROL FORMATION//INOSITOL 1 3 4 5 TETRAKISPHOSPHATE//BRAIN CORTICAL SLICES |
4 | 0.0000097744 | N ACETYL ASPARTATE//N ACETYLASPARTATE//MOL DYNAM MENTAL DISORDERS |
5 | 0.0000095005 | BRAIN PHYSIOL METAB SECT//ARACHIDONIC//IN VIVO INCORPORATION |
6 | 0.0000089798 | GLYCOGEN SYNTHASE KINASE 3//GSK 3//GLYCOGEN SYNTHASE KINASE 3 BETA |
7 | 0.0000081075 | CENTPROPAZINE//ISOPRENALINE INDUCED DRINKING//BETA DOWN REGULATION |
8 | 0.0000073887 | LITHIUM RESISTANCE//4C4//BLOOD LITHIUM |
9 | 0.0000059662 | LITHIUM INTOXICATION//LITHIUM TOXICITY//SERUM LITHIUM LEVELS |
10 | 0.0000056291 | H 3 IMIPRAMINE BINDING//IMIPRAMINE BINDING//H 3PAROXETINE BINDING |